Eosinophilia, IL-5 level and recovery of larvae in IL-5 transgenic mice infected with Toxocara canis

被引:24
|
作者
Sugane, K
Kusama, Y
Takamoto, M
Tominaga, A
Takatsu, K
机构
[1] KOCHI MED SCH,DEPT MED BIOL,KOCHI,JAPAN
[2] UNIV TOKYO,INST MED SCI,DEPT IMMUNOL,TOKYO,JAPAN
关键词
D O I
10.1017/S0022149X00015315
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Eosinophil counts, interleukin 5 (IL-5) concentrations in peripheral blood and larval recovery after infection with Toxocara canis were compared between IL-5 transgenic (Tg) and nontransgenic counterparts, C3H/HeN mice. In Tg mice characterized by a constant high level of peripheral eosinophils, eosinophils in peripheral blood fell to the lowest level on day 4 of a T. canis infection and then returned to the preinfection level on day 14. Serum IL-5 level fell to the lowest level on day 4 of infection, then recovered rapidly and peaked on day 14 postinfection. Ln contrast, the eosinophil and IL-5 levels in the peripheral blood peaked on days 11 and 7 of infection, respectively in C3H/HeN mice. The degree of eosinophil infiltration into the lung 4 days after infection was far more pronounced in Tg than C3H/HeN mice. The highest number of larvae recovered from the lungs of infected Tg and C3H/HeN mice occurred on day 4 postinfection. Strains of Tg and C3H/HeN mice vaccinated with excretory and secretory (ES) antigens of T. canis larvae were infected with T. canis and the recovery of larvae on day 21 analysed. There were no significant differences in the mean number of larvae recovered from nonvaccinated Tg and C3H/HeN mice or vaccinated Tg and C3H/HeN mice. However, significant differences were demonstrated in the mean total number of larvae recovered from vaccinated and nonvaccinated Tg or C3H/HeN mice. These results suggest that immunocompetent cells other than eosinophils may play a significant role in the expulsion and killing of T. canis larvae in infected mice.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 50 条
  • [1] INVIVO ADMINISTRATION OF ANTIBODY TO MURINE IL-5 RECEPTOR INHIBITS EOSINOPHILIA OF IL-5 TRANSGENIC MICE
    HITOSHI, Y
    YAMAGUCHI, N
    KORENAGA, M
    MITA, S
    TOMINAGA, A
    TAKATSU, K
    INTERNATIONAL IMMUNOLOGY, 1991, 3 (02) : 135 - 139
  • [2] IL-5 and eosinophilia
    Takatsu, Kiyoshi
    Nakajima, Hiroshi
    CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (03) : 288 - 294
  • [3] IL-5 and IL-5 receptor in asthma
    Kotsimbos, ATC
    Hamid, Q
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1997, 92 : 75 - 91
  • [4] The role of interleukin-5 (IL-5) in vivo: Studies with IL-5 deficient mice
    Matthaei, KI
    Foster, PS
    Young, IG
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1997, 92 : 63 - 68
  • [5] IL-5 and IL-5 Receptor Blockers in refractory DRESS
    Oberhofer, Elke
    ALLERGO JOURNAL, 2023, 32 (04) : 16 - 17
  • [6] Immune responses of IL-5 transgenic mice to parasites and aeroallergens
    Dent, LA
    Daly, C
    Geddes, A
    Cormie, J
    Finlay, DA
    Bignold, L
    Hagan, P
    Parkhouse, RME
    Garate, T
    Parsons, J
    Mayrhofer, G
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1997, 92 : 45 - 54
  • [7] Eosinophilopoiesis in a murine model of allergic airway eosinophilia:: Involvement of bone marrow IL-5 and IL-5 receptor α
    Tomaki, M
    Zhao, LL
    Lundahl, J
    Sjöstrand, M
    Jordana, M
    Lindén, A
    O'Byrne, P
    Lötvall, J
    JOURNAL OF IMMUNOLOGY, 2000, 165 (07): : 4040 - 4050
  • [8] Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice
    L Stevceva
    P Pavli
    A Husband
    KI Matthaei
    IG Young
    WF Doe
    Genes & Immunity, 2000, 1 : 213 - 218
  • [9] Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice
    Stevceva, L
    Pavli, P
    Husband, A
    Matthaei, KI
    Young, IG
    Doe, WF
    GENES AND IMMUNITY, 2000, 1 (03) : 213 - 218
  • [10] Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice
    Zou, Yu
    Sonderegger, Ivo
    Lipowsky, Gerd
    Jennings, Gary T.
    Schmitz, Nicole
    Landi, Marco
    Kopf, Manfred
    Bachmann, Martin F.
    VACCINE, 2010, 28 (18) : 3192 - 3200